CHRM3 (rs2165870) 基因多态性与腹腔镜手术的女性患者的术后吐有关. 预期的观察性研究
1Department of Anesthesiology, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
PloS one
|August 20, 2024
概括
CHRM3 rs2165870多态性增加了腹腔镜手术的女性手术后吐的风险. 具体来说,AA基因型或A基因组与这种常见的手术并发症的更高发病率有关.
科学领域:
- 麻醉学和外科手术期间的医学.
- 人类遗传学 人类遗传学
- 手术并发症 手术并发症
背景情况:
- 手术后恶心和吐 (PONV) 是常见的并发症,不成比例地影响女性手术患者.
- 识别遗传倾向可以帮助预测和管理PONV风险.
- 腹腔镜手术在疼痛和吐管理方面提出了独特的挑战.
研究的目的:
- 调查CHRM3 rs2165870基因多态化与术后吐的发生率之间的关联.
- 探索KCNB2 rs349358多态性在腹腔镜手术后术后吐中的作用.
- 为了分析手术后吐的风险因素,在接受腹腔镜手术的女性患者.
主要方法:
- 预计将招募200名接受选择性腹腔镜手术的女性患者.
- 使用MassARRAY SNP技术进行CHRM3 rs2165870和KCNB2 rs349358多态的基因定型.
- 收集人口统计数据,实验室结果和术后结果,包括PONV发病率.
主要成果:
- CHRM3 rs2165870多态性,特别是AA基因型或A等位基因,与术后吐风险增加显著相关 (OR=6.94对于AA与GG;P=0.014).
- 没有发现KCNB2 rs349358多态化与术后恶心或吐率 (P>0.05) 之间有显著的关联.
- 人口特征在基因型组之间没有显著差异.
结论:
- CHRM3 rs2165870多态性是腹腔镜手术后女性患者术后吐的重要危险因素.
- CHRM3 rs2165870的AA基因型或A基因基因可能会使个体易于患上术后吐.
- 对基因标记物的进一步研究可以完善PONV风险评估和个性化麻醉管理.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
Pathophysiology of Vomiting
348
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
348
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
66
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
66


